Summary
Cotherix is a specialty pharmaceutical company that develops and markets innovative prescription drugs for people with diseases and medical conditions that have few or no satisfactory treatment options.
History
Cotherix is a dynamic and innovative pharmaceutical company, formed in 2012 to focus on the development and commercialization of novel pharmaceutical products globally. The company has grown and expanded its operations, manufacturing and product portfolio. Core products and specialty clinical products are available in the US and Canada, with a comprehensive portfolio of products leveraging expertise and development capabilities in major therapeutic areas.
Mission
Our mission is to help improve the lives of those affected by serious and often life-threatening diseases and medical conditions. We achieve this through developing, manufacturing, and commercializing innovative treatments that have the potential to address key areas of unmet medical need.
Vision
Cotherix strives to become a recognized leader in the development, manufacturing, and commercialization of innovative treatments to address unmet medical needs, while also striving to remain a trusted partner to physicians, patients, caregivers, and other partners.
Key Team
Recognition and Awards
Our products have received numerous awards and citations, including the 2016 European Association of Pharmaceutical Industries and Associations Business Excellence Award, the 2017 American Society of Clinical Oncology Chairman’s Award, and the 2017 American Society of Clinical Oncology Trailblazer in Oncology Innovation Award, among others.
References